Jiangsu Tianyan Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Eyebright Medical Technology Co., Ltd.
Jiangsu Tianyan Pharmaceutical Technology Co., Ltd. announced that it will receive CNY 20,000,000 in a round of funding from new investor Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) on March 30, 2021. The investor will acquire 55% stake along with merger transaction. The transaction has been reviewed and approved at the 23rd meeting of the first board of directors of the investor.